Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab.

Pérez de Llano LA, Dacal Rivas D, Cosío BG.

Allergy. 2019 Sep 4. doi: 10.1111/all.14035. [Epub ahead of print] No abstract available.

PMID:
31483864
2.

Severe T2-high asthma in the biologics era: European experts' opinion.

Pavord I, Bahmer T, Braido F, Cosío BG, Humbert M, Idzko M, Adamek L.

Eur Respir Rev. 2019 Jul 8;28(152). pii: 190054. doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30. Review.

3.

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.

Millares L, Pascual S, Montón C, García-Núñez M, Lalmolda C, Faner R, Casadevall C, Setó L, Capilla S, Moreno A, Castro-Acosta AA, Alvarez-Martinez CJ, Sibila O, Peces-Barba G, Cosio BG, Agustí A, Gea J, Monsó E.

BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.

4.

Circulating miRNAs as diagnostic tool for discrimination of respiratory disease: Asthma, asthma-chronic obstructive pulmonary disease (COPD) overlap and COPD.

Rodrigo-Muñoz JM, Rial MJ, Sastre B, Cañas JA, Mahíllo-Fernández I, Quirce S, Sastre J, Cosío BG, Del Pozo V.

Allergy. 2019 May 24. doi: 10.1111/all.13916. [Epub ahead of print] No abstract available.

PMID:
31125431
5.

Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.

Pérez de Llano L, Martínez-Moragón E, Plaza Moral V, Trisan Alonso A, Sánchez CA, Callejas FJ, Vera E, Soto Campos JG, Martinez Rivera C, Alcázar Navarrete B, Urrutia Landa I, Garcia Rivero JL, Padilla Galo A, Alvarez Gutierrez F, Landete P, Ramos González J, Aracil CF, Carretero Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Cosío BG.

Respir Med. 2019 May;151:49-54. doi: 10.1016/j.rmed.2019.03.006. Epub 2019 Apr 1. No abstract available.

PMID:
31047117
6.

Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.

Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, Entrenas Costa LM, Quirce S, Barranco P, Marina Malanda N, Andrés LP, Alvarez-Gutiérrez FJ.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2277-2283.e2. doi: 10.1016/j.jaip.2019.01.017. Epub 2019 Jan 21.

7.

ACO: Time to move from the description of different phenotypes to the treatable traits.

Toledo-Pons N, van Boven JFM, Román-Rodríguez M, Pérez N, Valera Felices JL, Soriano JB, Cosío BG.

PLoS One. 2019 Jan 24;14(1):e0210915. doi: 10.1371/journal.pone.0210915. eCollection 2019.

8.

10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain -A Summary of the EPISCAN II Protocol.

Alfageme I, de Lucas P, Ancochea J, Miravitlles M, Soler-Cataluña JJ, García-Río F, Casanova C, Rodríguez González-Moro JM, Cosío BG, Sánchez G, Soriano JB.

Arch Bronconeumol. 2019 Jan;55(1):38-47. doi: 10.1016/j.arbres.2018.05.011. Epub 2018 Jul 7. English, Spanish.

9.

The dose of inhaled corticosteroids in patients with COPD: when less is better.

Izquierdo JL, Cosio BG.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 25;13:3539-3547. doi: 10.2147/COPD.S175047. eCollection 2018. Review.

10.

Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up.

Borràs-Santos A, Garcia-Aymerich J, Soler-Cataluña JJ, Vigil Giménez L, Gea Guiral J, Rodríguez Chiaradía D, Pascual-Guardia S, Marcos Rodríguez PJ, Alvarez Martinez CJ, Casanova Macario C, López-Campos JL, Carrasco Hernández L, Martínez-González C, Santos-Pérez S, Peces-Barba G, Molina Paris J, Román Rodríguez M, Barberà JA, Faner R, Agustí A, Cosío BG; en representación del Grupo Investigador del estudio EARLY COPD.

Arch Bronconeumol. 2019 Jun;55(6):312-318. doi: 10.1016/j.arbres.2018.09.007. Epub 2018 Nov 11. English, Spanish.

11.

The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.

Gea J, Pascual S, Castro-Acosta A, Hernández-Carcereny C, Castelo R, Márquez-Martín E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosío BG, Agustí A; en representación del grupo BIOMEPOC; Anexo. Miembros del grupo BIOMEPOC.

Arch Bronconeumol. 2019 Feb;55(2):93-99. doi: 10.1016/j.arbres.2018.07.026. Epub 2018 Oct 19. English, Spanish.

12.

Asthma-COPD overlap: identification and optimal treatment.

Cosío BG, Dacal D, Pérez de Llano L.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618805662. doi: 10.1177/1753466618805662. Review.

13.

What is early COPD and why is it important?

Soriano JB, Polverino F, Cosio BG.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801448. doi: 10.1183/13993003.01448-2018. Print 2018 Dec.

PMID:
30309976
14.

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.

PMID:
30179741
15.

Temporal transitions in COPD severity stages within the GOLD 2017 classification system.

Soriano JB, Hahsler M, Soriano C, Martinez C, de-Torres JP, Marín JM, de Lucas P, Cosio BG, Fuster A, Casanova C; CHAIN investigators.

Respir Med. 2018 Sep;142:81-85. doi: 10.1016/j.rmed.2018.07.019. Epub 2018 Aug 3.

PMID:
30170807
16.

Bone marrow characterization in COPD: a multi-level network analysis.

Toledo-Pons N, Noell G, Jahn A, Iglesias A, Duran MA, Iglesias J, Rios A, Scrimini S, Faner R, Gigirey O, Agustí A, Cosío BG.

Respir Res. 2018 Jun 15;19(1):118. doi: 10.1186/s12931-018-0824-x.

17.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 12;13:591-601. doi: 10.2147/COPD.S153694. eCollection 2018.

18.

Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort.

Martínez-González C, Casanova C, de-Torres JP, Marín JM, de Lucas P, Fuster A, Cosío BG, Calle M, Peces-Barba G, Solanes I, Agüero R, Feu-Collado N, Alfageme I, Romero Plaza A, Balcells E, de Diego A, Marín Royo M, Moreno A, Llunell Casanovas A, Galdiz JB, Golpe R, Lacárcel Bautista C, Cabrera C, Marin A, Soriano JB, Lopez-Campos JL; CHAIN Study Investigators.

Chest. 2018 Aug;154(2):274-285. doi: 10.1016/j.chest.2018.02.007. Epub 2018 Feb 22.

PMID:
29476876
19.

The post-truth behind the asthma-COPD overlap and the orbit of Mercury: lessons from the CHACOS study.

Pérez de Llano L, López-Campos JL, Cosío BG.

Arch Bronconeumol. 2018 Apr;54(4):175-176. doi: 10.1016/j.arbres.2018.01.004. Epub 2018 Feb 17. English, Spanish. No abstract available.

20.

The Role of FENO in the Diagnosis and Control of Asthma. Expert Multidisciplinary Group Debate during the Asthma Meeting Point 2017.

Plaza V, Cosio BG, Entrenas LM, Olaguíbel JM, Pérez de Llano L, Quirce S; miembros del Grupo Multidisciplinar del Asma Meeting Point (AMP) 2017.

Arch Bronconeumol. 2018 Apr;54(4):237-238. doi: 10.1016/j.arbres.2017.09.016. Epub 2017 Dec 20. English, Spanish. No abstract available.

21.

Functional respiratory assessment before lung volume reduction in patients with emphysema.

Verdú J, Cosío BG, Sauleda J.

Arch Bronconeumol. 2018 May;54(5):251-252. doi: 10.1016/j.arbres.2017.11.001. Epub 2017 Dec 16. English, Spanish. No abstract available.

22.

Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.

Pérez de Llano L, Cosío BG, Miravitlles M, Plaza V; CHACOS study group.

Arch Bronconeumol. 2018 Apr;54(4):198-204. doi: 10.1016/j.arbres.2017.10.007. Epub 2017 Dec 9. English, Spanish.

23.

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.

Miravitlles M, Cosío BG, Arnedillo A, Calle M, Alcázar-Navarrete B, González C, Esteban C, Trigueros JA, Rodríguez González-Moro JM, Quintano Jiménez JA, Baloira A.

Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y. Review.

24.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

25.

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.

Casanova C, Celli BR, de-Torres JP, Martínez-Gonzalez C, Cosio BG, Pinto-Plata V, de Lucas-Ramos P, Divo M, Fuster A, Peces-Barba G, Calle-Rubio M, Solanes I, Aguero R, Feu-Collado N, Alfageme I, De Diego A, Romero A, Balcells E, Llunell A, Galdiz JB, Marin M, Moreno A, Cabrera C, Golpe R, Lacarcel C, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Marin JM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701162. doi: 10.1183/13993003.01162-2017. Print 2017 Nov.

26.

Asthma-COPD overlap is not a homogeneous disorder: further supporting data.

Pérez-de-Llano L, Cosio BG; CHACOS study group.

Respir Res. 2017 Nov 2;18(1):183. doi: 10.1186/s12931-017-0667-x.

27.

The EASI model: A first integrative computational approximation to the natural history of COPD.

Agustí A, Compte A, Faner R, Garcia-Aymerich J, Noell G, Cosio BG, Rodriguez-Roisin R, Celli B, Anto JM.

PLoS One. 2017 Oct 10;12(10):e0185502. doi: 10.1371/journal.pone.0185502. eCollection 2017.

28.

Multi-level differential network analysis of COPD exacerbations.

Noell G, Cosío BG, Faner R, Monsó E, Peces-Barba G, de Diego A, Esteban C, Gea J, Rodriguez-Roisin R, Garcia-Nuñez M, Pozo-Rodriguez F, Kalko SG, Agustí A.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700075. doi: 10.1183/13993003.00075-2017. Print 2017 Sep.

29.

Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Rossi A, Butorac-Petanjek B, Chilosi M, Cosío BG, Flezar M, Koulouris N, Marin J, Miculinic N, Polese G, Samaržija M, Skrgat S, Vassilakopoulos T, Vukić-Dugac A, Zakynthinos S, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Review. Erratum in: Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:247.

30.

Is There room for Theophylline in COPD?

Toledo-Pons N, Cosío BG.

Arch Bronconeumol. 2017 Oct;53(10):539-540. doi: 10.1016/j.arbres.2017.05.022. Epub 2017 Jun 21. English, Spanish. No abstract available.

31.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, Pérez de Llano L, Quirce S, Román-Rodríguez M, Soler-Cataluña JJ, Miravitlles M.

Arch Bronconeumol. 2017 Aug;53(8):443-449. doi: 10.1016/j.arbres.2017.04.002. Epub 2017 May 8. English, Spanish.

32.

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Cosío BG, Casanova C, Antonio Riesco J, Simonet P, Rigau D, Soriano JB, Ancochea J.

Arch Bronconeumol. 2017 Jun;53(6):324-335. doi: 10.1016/j.arbres.2017.03.018. Epub 2017 May 3. English, Spanish.

33.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, Pérez de Llano L, Quirce S, Roman-Rodríguez M, Soler-Cataluña JJ, Plaza V.

Eur Respir J. 2017 May 1;49(5). pii: 1700068. doi: 10.1183/13993003.00068-2017. Print 2017 May. No abstract available.

34.

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?

Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ; on behalf of the CHACOS study group.

Eur Respir J. 2017 May 1;49(5). pii: 1602397. doi: 10.1183/13993003.02397-2016. Print 2017 May.

35.

Test of Adherence to Inhalers.

Plaza V, López-Viña A, Cosio BG; en representación del Comité Científico del Proyecto TAI.

Arch Bronconeumol. 2017 Jul;53(7):360-361. doi: 10.1016/j.arbres.2016.08.006. Epub 2016 Oct 15. English, Spanish. No abstract available.

36.

The inflammasome pathway in stable COPD and acute exacerbations.

Faner R, Sobradillo P, Noguera A, Gomez C, Cruz T, López-Giraldo A, Ballester E, Soler N, Arostegui JI, Pelegrín P, Rodriguez-Roisin R, Yagüe J, Cosio BG, Juan M, Agustí A.

ERJ Open Res. 2016 Jul 11;2(3). pii: 00002-2016. eCollection 2016 Jul.

37.

Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle M, Soler JJ, de-Torres JP, Marín JM, Martínez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I; CHAIN study.

PLoS One. 2016 Sep 29;11(9):e0160770. doi: 10.1371/journal.pone.0160770. eCollection 2016. Erratum in: PLoS One. 2016 Nov 2;11(11):e0166257.

38.

Chronic Obstructive Pulmonary Disease in Non-Smokers.

Toledo-Pons N, Cosío BG, Velasco MD, Casanova C.

Arch Bronconeumol. 2017 Feb;53(2):45-46. doi: 10.1016/j.arbres.2016.07.013. Epub 2016 Sep 16. English, Spanish. No abstract available.

39.

Reply to Chiappetta et al.

Shafiek H, Torrecilla JA, Cosío BG.

Eur J Cardiothorac Surg. 2017 Jan;51(1):195. doi: 10.1093/ejcts/ezw237. Epub 2016 Jun 29. No abstract available.

PMID:
27365076
40.

Usefulness of Bronchoscopic Probe-Based Confocal Laser Endomicroscopy in the Diagnosis of Pneumocystis jirovecii Pneumonia.

Shafiek H, Fiorentino F, Cosio BG, Kersul A, Thiberville L, Gómez C, Riera M, Martín ML, Martínez R, Noguera MA, Agustí A, Sauleda J.

Respiration. 2016;92(1):40-7. doi: 10.1159/000447431. Epub 2016 Jul 1.

41.

Asthma, Chronic Obstructive Pulmonay Disease and Other Combinations.

Pérez de Llano LA, Cosío BG.

Arch Bronconeumol. 2016 Oct;52(10):499-500. doi: 10.1016/j.arbres.2016.03.003. Epub 2016 Apr 25. English, Spanish. No abstract available.

42.

Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.

Cosío BG, Shafiek H, Iglesias A, Yanez A, Córdova R, Palou A, Rodriguez-Roisin R, Peces-Barba G, Pascual S, Gea J, Sibila O, Barnes PJ, Agusti A.

Chest. 2016 Jul;150(1):123-30. doi: 10.1016/j.chest.2016.04.011. Epub 2016 Apr 21.

PMID:
27107490
43.

Risk of postoperative complications in chronic obstructive lung diseases patients considered fit for lung cancer surgery: beyond oxygen consumption.

Shafiek H, Valera JL, Togores B, Torrecilla JA, Sauleda J, Cosío BG.

Eur J Cardiothorac Surg. 2016 Oct;50(4):772-779. Epub 2016 Apr 7.

PMID:
27059429
44.

Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.

Sibila O, Garcia-Bellmunt L, Giner J, Rodrigo-Troyano A, Suarez-Cuartin G, Torrego A, Castillo D, Solanes I, Mateus EF, Vidal S, Sanchez-Reus F, Sala E, Cosio BG, Restrepo MI, Anzueto A, Chalmers JD, Plaza V.

Ann Am Thorac Soc. 2016 May;13(5):636-42. doi: 10.1513/AnnalsATS.201512-797OC.

45.

Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life.

van Boven JF, Román-Rodríguez M, Palmer JF, Toledo-Pons N, Cosío BG, Soriano JB.

Chest. 2016 Apr;149(4):1011-20. doi: 10.1016/j.chest.2015.12.002. Epub 2015 Dec 14.

PMID:
26836892
46.

Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.

Plaza V, Crespo A, Giner J, Merino JL, Ramos-Barbón D, Mateus EF, Torrego A, Cosio BG, Agustí A, Sibila O.

J Investig Allergol Clin Immunol. 2015;25(6):431-7.

47.

Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients.

Plaza V, López-Viña A, Entrenas LM, Fernández-Rodríguez C, Melero C, Pérez-Llano L, Gutiérrez-Pereyra F, Tarragona E, Palomino R, Cosio BG.

COPD. 2016 Oct;13(5):547-54. doi: 10.3109/15412555.2015.1118449. Epub 2016 Jan 20.

PMID:
26788620
48.

Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD.

Cosío BG, Jahn A, Iglesias A, Shafiek H, Busquets X, Agustí A.

BMC Pulm Med. 2015 Dec 7;15:157. doi: 10.1186/s12890-015-0155-3.

49.

Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations.

Shafiek H, Fiorentino F, Merino JL, López C, Oliver A, Segura J, de Paul I, Sibila O, Agustí A, Cosío BG.

PLoS One. 2015 Sep 9;10(9):e0135199. doi: 10.1371/journal.pone.0135199. eCollection 2015.

50.

Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, Marín JM, Martínez-Gonzalez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I, Casanova C; CHAIN Study.

Chest. 2016 Jan;149(1):45-52. doi: 10.1378/chest.15-1055. Epub 2016 Jan 6.

PMID:
26291753

Supplemental Content

Loading ...
Support Center